Deirdre Lawson
Internal Medicine · Leesburg, GANPI 1225132699
Payments from drug & device makers
Across 64 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$190
- Lilly USA, LLC$154
- Pfizer$110
- Amgen$87
- Novo Nordisk$82
- Boehringer Ingelheim$79
- plus $531 from 17 others
What the payments were for
- Food & beverage$1,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 7 | $190 |
| Lilly USA, LLC | 10 | $154 |
| Pfizer | 5 | $110 |
| Amgen | 5 | $87 |
| Novo Nordisk | 5 | $82 |
| Boehringer Ingelheim | 2 | $79 |
| Dexcom, Inc. | 4 | $68 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Merck | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Novartis | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Hologic Sales And Service, LLC | 2 | $32 |
| AstraZeneca | 2 | $30 |
| EMD Serono, Inc. | 1 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| GSK | 1 | $12 |
How this compares
$1,233 in reported general payments places this provider in the 70th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 135 | $43,481 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 31 | $6,832 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 28 | $1,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerAbrysvo | $110 | $43,481135 claims |
| GSKShingrix | $12 | $6,83231 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Leesburg
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.